Yüklüyor......
Taking Control Of Compliance
The cost of biologic therapies adds urgency to the need to develop realistic compliance strategies. By engaging and educating both the physician and patient, some MCOs are working hard to address at what has always been a complicated and formidable issue.
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioCommunications LLC
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3541840/ https://ncbi.nlm.nih.gov/pubmed/23319920 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|